GMMMG holds open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by GMMMG for information or approval, as appropriate.

Consultations typically run for six weeks, and comments are invited from all stakeholders across Greater Manchester. You can comment on current proposals via the links in the table below.

Please direct any questions to the secretariat at nuth.enquiries.gmmmg@nhs.net.

Title Information Feedback End Date
GMMMG Clinical Reference Group proposed actions from February 2024 On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the February 2024 CRG meeting. This consultation period is open until 5pm on Thursday 28th March 2024. Feedback Form March 28th, 2024
DOAC review and switch to apixaban for NVAF patients On behalf of the GMMMG Clinical Reference Group, we now seek comments on a draft guide on DOAC review and switch to apixaban for NVAF patients. This consultation period is open until 5pm on Friday 29th March 2024. Feedback Form March 29th, 2024
Primary Care Rebate Schemes ethical framework On behalf of the GMMMG Medicines Value Group, we now seek comments on an update to the GMMMG Ethical Framework for Considering Rebate Applications from Pharmaceutical, Nutrition and Device Companies in primary care. NB: this consultation includes two documents, provided in a zipped folder.
This consultation period is open until 5pm on Wednesday 3rd April 2024.
Feedback Form April 3rd, 2024
Statins for primary CV prevention in HIV Following discussion at the February 2024 meeting of CRG, we now seek comments on a draft position statement on prescribing statins for primary prevention in HIV.
This consultation period is open until 5pm on Friday 12th April 2024.
Feedback Form April 12th, 2024